Senior Clinical Scientist

The role

You will drive early-phase development in oncology and endocrinology indications. You will integrate preclinical findings into clinical strategies, design Phase 1-2 clinical trials, and author regulatory filings.

What you will do

• Develop clinical study Protocols, Investigator’s Brochures (IBs), and Informed Consent Forms (ICFs) for Phase 1–2 studies
• Author clinical sections for global IND and CTA submissions
• Respond to inquiries from health authorities
• Prepare protocol amendments and contribute to Clinical Study Reports (CSRs)
• Support the Medical Director with medical monitoring and data review activities
• Evaluate safety, efficacy, PK and PD trends
• Prepare and present data at Safety Monitoring Committee (SMC) meetings
• Act as the Clinical Development liaison across the organization
• Collaborate with Translational Science, Biometrics, Regulatory Affairs, Clinical Operations, and Quality Assurance
• Engage with medical experts and study investigators

Required qualifications

• Advanced scientific degree (Ph.D., PharmD, M.S. in Life Sciences, or equivalent)
• 5+ years of experience in biopharmaceutical clinical development
• At least 1 year dedicated to early-phase (Phase 1–2) clinical trials
• Background in Oncology or Endocrinology/Metabolic diseases
• Knowledge of GCP, ICH guidelines, clinical trial design, medical monitoring, data review, dose-finding strategies, PK and PD assessments
• Strong problem-solving skills

Nice to have

• MD welcomed

Benefits

• Equity
• Annual bonus dependent on team and company performance
• 6% (non-match) RRSP contribution
• CAD $1,500 annual Active Lifestyle Allowance
• Annual vacation
• Professional development opportunities
• Comprehensive health benefits
• Scientific and technical mentorship

Before you apply

• Refer to Job ID 23424 in your cover letter
• Only selected candidates will be contacted for an interview

About the company

AbCellera is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.